Q4 2025 RPG Life Sciences Limited Earnings Call Transcript
Key Points
- RPG Life Sciences Ltd (BOM:532983) reported a strong Q4 FY25 performance with business growth of 12.7%, significantly outpacing market growth.
- The company achieved impressive profit growth with EBITDA increasing by 37%, PBT by 41%, and PAT by 40%.
- Margins improved significantly, with EBITDA margin rising from 17.6% to 21.4%, PBT margin from 14% to 17.5%, and PAT margin from 10.4% to 12.9%.
- The company has accumulated a substantial cash surplus of INR 163.7 crores from operations, and INR 266 crores including exceptional items.
- RPG Life Sciences Ltd (BOM:532983) has modernized its plants and expanded its R&D capabilities, positioning itself well for future growth.
- The company experienced a fire incident at its API plant, impacting operations and resulting in a loss of sales in Q4.
- There was a slight increase in receivables due to the expansion of the International Formulations business, which could affect cash flow.
- The Domestic Formulations segment faced pricing pressure due to DPCO regulations, impacting price growth.
- The API segment saw a slowdown in the second half of the year, partly due to the fire incident.
- R&D expenses are expected to increase as the company develops more molecules, which could impact short-term profitability.
Ladies and gentlemen, good day. Welcome to RPG Life Sciences Q4 FY25 results conference call, hosted by Dolat Capital Markets Private Limited.
(Operator Instructions)
I now hand the conference over to Ms. Rashmi Shetty. Thank you and over to you, ma'am.
Thank you, [Pooja]. Good afternoon, everyone.
I, Rashmi Shetty, on behalf of Dolat Capital, welcome you to the Q4 FY25 earnings call of RPG Life Sciences. We thank the RPG Life management for giving us this opportunity to host the call.
Today, we have with us the senior management of the company, represented by Mr. Yugal Sikri, Managing Director; Mr. Ashok Nair, Designated Managing Director; and Mr. Vishal Shah, CFO.
I would now hand over the call to the company management for the opening remarks. Over to you, sir.
Hello. Thank you, Rashmi. Good afternoon, everyone. Thank you very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
